These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34143299)

  • 41. Early effects of streptozotocin-induced diabetes on insulin-like growth factor-I in the kidneys of growth hormone-transgenic and growth hormone-deficient dwarf mice.
    Jacobs ML; Chandrashekar V; Bartke A; Weber RF
    Exp Nephrol; 1997; 5(4):337-44. PubMed ID: 9259189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone axis in chronic kidney disease.
    Mahesh S; Kaskel F
    Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency.
    Hoogenberg K; Sluiter WJ; Dullaart RP
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):151-7. PubMed ID: 8372600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
    Clark RG
    Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
    Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
    J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone hypothesis and development of diabetic nephropathy in Type 1 diabetes.
    Amin R; Dunger DB
    Expert Rev Endocrinol Metab; 2006 Sep; 1(5):673-684. PubMed ID: 30754096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth.
    Blutke A; Schneider MR; Wolf E; Wanke R
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
    Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth hormone treatment in pre-pubertal short Chinese children with chronic kidney disease prior to transplantation.
    Tang X; Chen Q; Chen J; Fang X; Zhang A; Zhao F; Huang W; Wang P; Sun L; Xiao H; Xu K; Liu X; Chen Z; Chen C; Tu J; Wu Y; Wang X; Mao J; Lu Z; Wang J; Nie X; Yu Z; Huang J; Liu C; Cao G; Li Y; Zhu Y; Zhang J; Wang M; Wang M; Yang H; Shen Q; Xu H
    Pediatr Res; 2023 Jul; 94(1):268-274. PubMed ID: 36539574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The aging suppressor klotho: a potential regulator of growth hormone secretion.
    Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of growth hormone and IGF-I on renal function.
    Hirschberg R; Kopple JD
    Kidney Int Suppl; 1989 Nov; 27():S20-6. PubMed ID: 2636657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3.
    Caverzasio J; Montessuit C; Bonjour JP
    Endocrinology; 1990 Jul; 127(1):453-9. PubMed ID: 2361480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
    Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
    Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
    Oh Y
    Kidney Res Clin Pract; 2012 Mar; 31(1):26-37. PubMed ID: 26889406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.